Question explored with the scientific record
What harms have the covid vaccines caused
The short version: the evidence shows a clear, dose-linked risk of heart inflammation in young men, plus case reports of severe bleeding and sudden death, but the long-term picture is almost entirely unstudied.
The strongest signal comes from a large Italian cohort study [1]. In young men aged 16-19 who received the Moderna vaccine, the number needed to harm for myocarditis was 7,213, meaning one extra case of heart inflammation for every 7,213 doses. The same study found a hazard ratio of 5.5 for myocarditis and 2.2 for pericarditis in the vaccinated group overall. A biopsy-proven case series of 15 patients [4] confirmed that the inflammation is real, not just a lab finding: some patients had ejection fractions as low as 5%, meaning their hearts were barely pumping. A separate Japanese case series [2] documented five young men who died or suffered cardiac arrest within days of mRNA vaccination, with autopsy findings of myocarditis and contraction band necrosis, a pattern of heart muscle death.
Beyond the heart, a case report [5] documented a 74-year-old man whose platelet count crashed from 224 to 10 within a day of the Moderna vaccine, a severe immune-driven bleeding disorder that required multiple drugs and transfusions to stabilize. The evidence does not include a single long-term safety study comparing vaccinated to unvaccinated people. Every study here is either a short-term cohort or a case series. The most informative design, a randomized trial with years of follow-up and a true placebo group, was never run.
| Outcome | Population | Risk estimate | Source |
|---|---|---|---|
| Myocarditis (Moderna) | Males 16-19 | NNH 7,213 | [1] |
| Myocarditis (overall) | All vaccinated | HR 5.5 (95% CI 3.7-8.1) | [1] |
| Pericarditis (overall) | All vaccinated | HR 2.2 (95% CI 1.5-3.1) | [1] |
| Severe thrombocytopenia | 74-year-old man | Platelets 10 x10⁹/L | [5] |
| Cardiac arrest/death | Young males (5 cases) | Days post-vaccination | [2] |
My call: the evidence proves a real, biologically confirmed risk of heart inflammation in young men and documents rare but severe hematologic and cardiac events. The magnitude of harm is not trivial for the affected individuals, and the absence of long-term safety data means the full picture is unknown. Confidence: moderate for myocarditis in young men, low for everything else because the studies are too small or too short to detect rarer harms.
Sources examined 12
-
Increased risk of myocarditis and pericarditis and reduced likelihood of severe clinical outcomes associated with COVID-19 vaccination: a cohort study in Lombardy, Italy
This cohort study in Lombardy, Italy, assesses the increased risk of myocarditis and pericarditis associated with COVID-19 vaccination, particularly highlighting the higher incidence in young men after receiving the Moderna vaccine, while also demonstrating that the benefits of …
DOI: 10.1186/s12879-022-07823-3 -
Lessons Learnt from Case Series of Out-of-hospital Cardiac Arrest and Unexpected Death after COVID-19 Vaccination
This study reviews cases of out-of-hospital cardiac arrest and unexpected deaths following COVID-19 vaccination, highlighting the potential link between myocarditis, prominent J waves on ECG, and fatal arrhythmias, particularly in young men.
DOI: 10.2169/internalmedicine.2298-23 -
Myocarditis after COVID-19 mRNA vaccination: clinical observations and potential mechanisms
This study examines the incidence and implications of acute myocarditis associated with COVID-19 mRNA vaccination compared to myocarditis resulting from COVID-19 infection, highlighting the rarity of vaccine-related myocarditis and the greater risks associated with COVID-19 itse…
DOI: 10.1038/s41569-021-00662-w -
Intramyocardial Inflammation after COVID-19 Vaccination: An Endomyocardial Biopsy-Proven Case Series
This study presents a comprehensive histopathological analysis of endomyocardial biopsies from 15 patients with reduced ejection fraction and clinical suspicion of myocarditis following COVID-19 vaccination, revealing a high prevalence of myocardial inflammation and suggesting a…
DOI: 10.3390/ijms23136940 -
Severe, Refractory Immune Thrombocytopenia Occurring After SARS-CoV-2 Vaccine
This case report describes a 74-year-old man who developed severe, refractory immune thrombocytopenia shortly after receiving the Moderna SARS-CoV-2 vaccine, highlighting the potential for vaccine-related adverse effects and the challenges in treatment.
DOI: 10.2147/JBM.S307047 -
Acute flaccid myelitis: long-term outcomes recorded in the CAPTURE study compared with paediatric transverse myelitis
A prospective, multicenter CAPTURE study compared long-term outcomes in pediatric acute flaccid myelitis (AFM) with transverse myelitis (TM), evaluated initial corticosteroid/PLEX versus IVIG treatments, identified two MRIPatterns in AFM, and found no clear superiority of the in…
DOI: 10.1136/bmjno-2021-000127 -
Clinical Problem-Solving: Lower Extremity Weakness & Paresthesia in an Immunocompromised Patient With a Complex Cancer History
A single-patient case report of a 51-year-old immunocompromised man with AML and CNS involvement who developed acute thoracic myelopathy; despite extensive testing and immunotherapy, the working diagnosis evolved, with CSF CMV PCR positivity ultimately favoring CMV myelitis over…
DOI: 10.1177/19418744211017396 -
Acute myelitis associated with dengue infection
A case report describing acute dengue-associated myelitis in a 24-year-old woman from Guadeloupe, detailing clinical presentation, MRI findings, steroid treatment, and partial recovery, highlighting dengue infection as a possible cause of myelitis.
DOI: 10.1016/j.medmal.2018.10.003 -
Varicella zoster virus transverse myelitis without cutaneous rash
This study presents a case of culture-confirmed varicella zoster virus (VZV) transverse myelitis in a patient without a cutaneous rash, highlighting the need to consider VZV as a potential cause of transverse myelitis even in atypical presentations.
DOI: 10.1016/0002-9343(90)90445-j -
Recurrent transverse myelitis in primary antiphospholipid syndrome—case report and literature review
This study presents a case of recurrent transverse myelitis in a patient with primary antiphospholipid syndrome, suggesting that this neurological complication should be recognized as a rare feature of the condition.
DOI: 10.1007/s00296-003-0399-8 -
Acute Myelitis in a Patient with Vogt-Koyanagi-Harada Disease: Case Report and Review of the Literature
This case report describes a 50-year-old woman with Vogt-Koyanagi-Harada disease who developed acute myelitis, highlighting the need for clinicians to consider this rare neurological manifestation and the potential common pathogenic pathways shared by VKH disease and acute myeli…
DOI: 10.3988/jcn.2013.9.1.61 -
Myelitis in systemic lupus erythematosus frequently manifests as longitudinal and sometimes occurs at low disease activity
This study investigates the clinical features and MRI findings of transverse myelitis in patients with systemic lupus erythematosus, revealing that it often presents as longitudinal myelitis and can occur even during periods of low disease activity.
DOI: 10.1177/0961203314541690